摘要
Background: MRI-derived pressure ratio (M-PR) and arterial spin labeling (ASL) perfusion reflect different aspects of cerebral hemodynamics. Whether pressure-based assessment provides better prognostic information than perfusion assessment in symptomatic intracranial atherosclerotic stenosis (ICAS) remains uncertain.
Aims: To evaluate whether M-PR provides better prognostic discrimination than ASL relative cerebral blood flow (rCBF) for predicting 2-year ipsilateral ischemic stroke or vascular death.
Methods: A total of 227 symptomatic patients with unilateral 50%–99% ICAS and baseline M-PR and ASL measurements were analyzed. The primary endpoint was ipsilateral-territory ischemic stroke or vascular death within 24 months of enrollment. ASL rCBF was defined as the ipsilateral-to-contralateral ratio of mean CBF across 14 paired regions. Analyses included mutually adjusted Cox regression and time-dependent receiver operating characteristic analysis accounting for censoring. Exploratory Kaplan–Meier analyses compared M-PR ≤0.55 versus >0.55 within low and high ASL rCBF categories, using a cohort-derived rCBF cutoff of 0.695.
Results: The primary endpoint occurred in 18 patients (7.9%), all of whom experienced ipsilateral ischemic stroke. After adjustment for ASL rCBF, higher M-PR was associated with lower endpoint risk (HR per standard deviation increase, 0.59; 95% CI, 0.39–0.90; P = 0.015). M-PR showed a numerically higher area under the curve (AUC) than ASL rCBF (0.653 versus 0.485; difference, 0.168; 95% CI, −0.012 to 0.348; P = 0.068). Combining the two markers yielded an AUC of 0.657, with little change from M-PR alone (P = 0.422). Estimated 24-month endpoint risks were numerically higher with M-PR ≤0.55 than >0.55 in both low rCBF (27.3% versus 10.1%; log-rank P = 0.164) and high rCBF strata (11.8% versus 5.6%; log-rank P = 0.104).
Conclusions: In symptomatic ICAS, M-PR was associated with the 2-year primary endpoint and showed numerically greater discrimination than ASL rCBF. Higher estimated risks in the low M-PR group within both perfusion strata further support its evaluation as a prognostic marker. Larger, independent cohorts are needed to establish whether these numerical advantages represent reproducible improvements in prediction.
